Cargando…
A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates
Despite the ease of production and improved safety profiles of recombinant vaccines, the inherently low immunogenicity of unadjuvanted proteins remains an impediment to their widespread adoption. The covalent tethering of TLR agonists to antigenic proteins offers a unique approach to co-deliver both...
Autores principales: | Massena, C. J., Lathrop, S. K., Davison, C. J., Schoener, R., Bazin, H. G., Evans, J. T., Burkhart, D. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118693/ https://www.ncbi.nlm.nih.gov/pubmed/33977971 http://dx.doi.org/10.1039/d1cc00795e |
Ejemplares similares
-
From Ugi Multicomponent Reaction to Linkers for Bioconjugation
por: Ramos-Tomillero, Iván, et al.
Publicado: (2020) -
Dually Reactive Long Recombinant Linkers for Bioconjugations
as an Alternative to PEG
por: Kjeldsen, Thomas, et al.
Publicado: (2020) -
Self-Adjuvanting
TLR7/8 Agonist and Fentanyl Hapten
Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge
por: Powers, Noah, et al.
Publicado: (2023) -
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate
por: Ravenscroft, Neil, et al.
Publicado: (2019) -
Characterization of covalent crosslinking strategies for synthesizing DNA-based bioconjugates
por: Wickramathilaka, Malithi P., et al.
Publicado: (2019)